The global artificial disc market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.8 Billion by 2033, exhibiting a growth rate (CAGR) of 15.24% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033 |
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 3.6 Billion |
Market Forecast in 2033 | USD 13.8 Billion |
Market Growth Rate 2025-2033 | 15.24% |
An artificial disc is an arthroplasty device that is implanted into the lumbar or cervical spine to imitate the function of damaged intervertebral discs. It is composed of two endplates that are generally made using medical-grade polyethylene, cobalt-chromium or titanium alloy. It is soft and compressible and helps relieve back pain while retaining movement and flexibility. Nowadays, artificial disc replacement, also known as arthroplasty, is gaining traction over fusion surgical procedures across various regions. Its eligibility is determined by doctors using several tests, such as X-rays, discography, computed tomography (CT) scans and magnetic resonance imaging (MRI).
The rising prevalence of degenerative disc disease (DDD), along with the growing geriatric population and increasing adoption of minimally invasive surgery (MIS), represents one of the key factors impelling the global artificial disc market growth. Moreover, rising awareness about the benefits of arthroplasty, along with reimbursements provided by insurance companies, is escalating the demand for artificial discs. Apart from this, governments of several countries are improving healthcare infrastructure and encouraging medical tourism, which represents another growth-inducing factor bolstering the market growth. However, due to the mass spread of the coronavirus disease (COVID-19), governments of numerous countries have imposed lockdowns and are encouraging social distancing measures. As a result, several medical centers have postponed non-essential arthroplasty procedures, which has impacted the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial disc market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on disc type, material type and end user.
Breakup by Disc Type:
Breakup by Material Type:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Depuy Synthes Inc. (Johnson & Johnson), Globus Medical Inc., Medtronic plc, Nuvasive Inc., Orthofix Medical Inc., Paradigm Spine LLC (RTI Surgical Holdings Inc.), Smith & Nephew Plc, Stryker Corporation and Zimmer Biomet Holdings Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Disc Type, Material Type, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Depuy Synthes Inc. (Johnson & Johnson), Globus Medical Inc., Medtronic plc, Nuvasive Inc., Orthofix Medical Inc., Paradigm Spine LLC (RTI Surgical Holdings Inc.), Smith & Nephew Plc, Stryker Corporation, Zimmer Biomet Holdings Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global artificial disc market was valued at USD 3.6 Billion in 2024.
We expect the global artificial disc market to exhibit a CAGR of 15.24% during 2025-2033.
The rising prevalence of Degenerative Disc Disease (DDD), along with the growing consumer awareness regarding the benefits of arthroplasty or artificial disc replacement, as it helps to relieve back pain while retaining movement and flexibility, is primarily driving the global artificial disc market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective arthroplasty or artificial disc replacement surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for artificial disc.
Based on the disc type, the global artificial disc market has been segmented into cervical artificial disc and lumbar artificial disc, where cervical artificial disc currently holds the majority of the total market share.
Based on the material type, the global artificial disc market can be divided into metal on polymer and metal on metal. Currently, metal on polymer exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global artificial disc market include B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Depuy Synthes Inc. (Johnson & Johnson), Globus Medical Inc., Medtronic plc, Nuvasive Inc., Orthofix Medical Inc., Paradigm Spine LLC (RTI Surgical Holdings Inc.), Smith & Nephew Plc, Stryker Corporation, and Zimmer Biomet Holdings Inc.